Imagine a new drug has hit the market. It’s supposed to “revolutionize” the care of diabetics all over America – it’s commercial said so remember!? Well, if you are the Director of Pharmacy at a large medical center, you probably wouldn’t take their word for it.
So, how do you decide whether it is worth adding to the hospital’s formulary or not?
33 Comments
|
Have an exciting topic about the managed care space or pharmaceutical industry you would like to share?
Showcase your writing skills and have your post featured in the AMCP-OSU Blog by reaching out to the VP of Communications, Pia Georgette Ang. Archives |